American Shared Hospital Services reported a net loss of $2,866,000 for the nine months ended September 30, 2026, compared to a loss of $1,719,000 in the prior year period. While total revenues increased to $23,138,000, higher operating costs and selling and administrative expenses led to an increased operating loss of $2,598,000.
AMS reports 13.7% nine-month revenue growth driven by direct patient services, but faces significant net losses and high legal costs due to debt restructuring.
American Shared Hospital Services Financial Results
American Shared Hospital Services reported Q3 2026 revenue of $7.6 million, a 6% increase year-over-year, driven by a 14% rise in Direct Patient Services revenue. The company generated $5.8 million in operating cash flow during the first nine months of 2026 and increased its cash position to approximately $9.5 million.
“During the third quarter, we continued to make progress in growing our Direct Patient Services business, with revenue in this segment increasing 14% year over year. For the first nine months of 2026, total revenue increased 14%, driven by continued growth in our Rhode Island radiation therapy operations and higher procedure volumes at our international Gamma Knife facilities.”
Craig Tagawa, Interim Chief Executive Officer
“We continue to focus on positioning the Company for long-term success by building on our established presence in radiation oncology and pursuing opportunities to expand the reach and capabilities of our technology and services.”